Landiolol hydrochloride is an ultra-short-acting beta-blocker used intravenously to rapidly control fast heart rates (tachycardia) and irregular rhythms like atrial fibrillation, particularly in critical settings like surgery (perioperative) or intensive care, due to its fast onset and short duration of action, minimizing effects on blood pressure. It works by slowing the heart, making it a valuable treatment for patients needing quick rate control, including those with respiratory issues or left ventricular dysfunction. It is grouped under the following drug class(es): Beta blockers. Its therapeutic use is listed as antiarrhythmics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Onoact and Rapiblyk (TN). Its PubChem CID is 164457.
Landiolol hydrochloride
| CAS No | 144481-98-1 |
|---|---|
| Molecular Formula | C25H40ClN3O8 |
| Molecular Weight | 546.10 g/mol |
| Synonyms | [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Landiolol hydrochloride is an ultra-short-acting beta-blocker used intravenously to rapidly control fast heart rates (tachycardia) and irregular rhythms like atrial fibrillation, particularly in critical settings like surgery (perioperative) or intensive care, due to its fast onset and short duration of action, minimizing effects on blood pressure.
The listed CAS number is 144481-98-1.
The listed molecular formula is C25H40ClN3O8.
The listed molecular weight is 546.10 g/mol.
[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate;hydrochloride.
The source lists Onoact and Rapiblyk (TN).